4-122612665-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021803.4(IL21):c.*45G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0638 in 1,330,264 control chromosomes in the GnomAD database, including 3,200 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.050 ( 278 hom., cov: 32)
Exomes 𝑓: 0.066 ( 2922 hom. )
Consequence
IL21
NM_021803.4 3_prime_UTR
NM_021803.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.176
Genes affected
IL21 (HGNC:6005): (interleukin 21) This gene encodes a member of the common-gamma chain family of cytokines with immunoregulatory activity. The encoded protein plays a role in both the innate and adaptive immune responses by inducing the differentiation, proliferation and activity of multiple target cells including macrophages, natural killer cells, B cells and cytotoxic T cells. Dysregulation of this gene plays a role in multiple immune-mediated diseases including lupus, psoriasis and chronic inflammatory diseases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 4-122612665-C-T is Benign according to our data. Variant chr4-122612665-C-T is described in ClinVar as [Benign]. Clinvar id is 1269619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0735 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL21 | NM_021803.4 | c.*45G>A | 3_prime_UTR_variant | 5/5 | ENST00000648588.1 | NP_068575.1 | ||
IL21 | NM_001207006.3 | c.*162G>A | 3_prime_UTR_variant | 4/4 | NP_001193935.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL21 | ENST00000648588.1 | c.*45G>A | 3_prime_UTR_variant | 5/5 | NM_021803.4 | ENSP00000497915 | P1 | |||
IL21 | ENST00000647784.1 | n.386G>A | non_coding_transcript_exon_variant | 4/4 | ||||||
IL21 | ENST00000611104.2 | downstream_gene_variant | 1 | ENSP00000477555 |
Frequencies
GnomAD3 genomes AF: 0.0505 AC: 7678AN: 152034Hom.: 278 Cov.: 32
GnomAD3 genomes
AF:
AC:
7678
AN:
152034
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0524 AC: 12896AN: 246312Hom.: 426 AF XY: 0.0537 AC XY: 7162AN XY: 133306
GnomAD3 exomes
AF:
AC:
12896
AN:
246312
Hom.:
AF XY:
AC XY:
7162
AN XY:
133306
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0655 AC: 77209AN: 1178112Hom.: 2922 Cov.: 16 AF XY: 0.0649 AC XY: 38955AN XY: 600354
GnomAD4 exome
AF:
AC:
77209
AN:
1178112
Hom.:
Cov.:
16
AF XY:
AC XY:
38955
AN XY:
600354
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0504 AC: 7672AN: 152152Hom.: 278 Cov.: 32 AF XY: 0.0510 AC XY: 3795AN XY: 74392
GnomAD4 genome
AF:
AC:
7672
AN:
152152
Hom.:
Cov.:
32
AF XY:
AC XY:
3795
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
55
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at